ROI Calculator
Two numbers every pharma MD
should know about their field force
What you are losing today — and what RouteX can unlock. Built from your inputs, not assumptions you didn't make.
Your field force — 3 numbers
Number of MRs
Total field force headcount
Monthly revenue per MR (₹)
₹
Average territory revenue per MR
Average prescription value (₹)
₹
₹300 General · higher for Specialty
Derived from your inputs — check these against your reality
Total visits / MR / month
200
8 visits/day × 25 days
Doctors per territory
80
Fixed — 200 visits ÷ 2.5 frequency
Prescriptions / doctor / month
12.5 Rx
Revenue ÷ Rx value ÷ 80 doctors
Revenue / doctor / month
₹3.8K
Monthly revenue ÷ 80 doctors
⬇ What you are losing today
Minimum ₹11.25L leaking out every month — right now
This is the conservative floor. On manual reporting systems, 15% of visits are ghost visits. Here is the chain from ghost visits to lost revenue — using only your numbers.
20,000
Visits per month
(team total)
(team total)
→
3,000
Ghost visits
(15% of total)
(15% of total)
→
300
Doctors lost
(1 per 10 ghost visits)
(1 per 10 ghost visits)
→
₹11.25L/mo
Revenue at risk
per month
per month
Why 1 in 10? Ghost visits don't distribute evenly. They cluster on the same doctors — the hard-to-reach clinic, the doctor who keeps the MR waiting. Not every ghost visit loses a doctor permanently. But 1 in every 10 represents a doctor being systematically under-visited — missed so consistently that the relationship is degrading. That doctor is the minimum cost of manual reporting.
Total visits / month (team)
MRs × 8 visits/day × 25 days
20,000 visits
Ghost visits / month
Total visits × 15% ghost rate
3,000 visits
Doctors effectively lost
Ghost visits ÷ 10
300 doctors
Prescriptions per doctor / month
Monthly revenue ÷ Rx value ÷ 80 doctors
12.5 Rx
Revenue at risk / month
Doctors lost × Prescriptions per doctor × Rx value
₹11.25L/mo
Revenue at risk / year
Monthly × 12
₹1.35Cr/yr
⬆ What RouteX can unlock
₹1.75Cr in additional revenue waiting to be captured
Two separate opportunities — relationships you can recover, and competitor prescribers you can convert. Neither is visible without the right tools.
Opportunity 1 — Recover dropped relationships
Ghost visits cluster on the same 3 doctors per MR, month after month. A doctor missed for 2+ consecutive months has a 50% chance of switching to a competitor. RouteX flags these doctors before the relationship is gone — with missed visit alerts and a Needs Attention dashboard that identifies at-risk doctors by name, early enough to act.
Doctors at serious relationship risk
300 doctors
3 per MR, missed 2+ months running
Revenue recoverable / month
₹5.63L
at 50% switching risk per cluster doctor
Revenue recoverable / year
₹67.50L
from recovered doctor relationships
Cluster doctors across team
MRs × 3 doctors per MR
300 doctors
Revenue per doctor / month
Monthly revenue per MR ÷ 80 doctors
₹3.8K/mo
Revenue recoverable / month
Cluster doctors × Revenue per doctor × 50% switching risk
₹5.63L/mo
Revenue recoverable / year
Monthly × 12 months
₹67.50L/yr
Opportunity 2 — Convert invisible competitor prescribers
In a typical 80-doctor territory, 30% of doctors are writing a competitor brand for a molecule your MR also promotes. Without RCPA data collected at the chemist, your MRs have no way of knowing who they are. With RouteX RCPA, competitor prescribers are identified on the same day the data is collected — and can be targeted immediately. Conservative conversion: 10% of those doctors over 6 months.
Competitor prescribers invisible without RCPA
2,400 doctors
30% of 80 doctors per territory
Convertible with RCPA intelligence
240 doctors
10% conversion in 6 months — conservative
New revenue opportunity / year
₹1.08Cr
from competitor prescriber conversion
Competitor prescribers per territory
80 doctors × 30% competitor rate
24 doctors
Competitor prescribers — team total
MRs × 24 per territory
2,400 doctors
Convertible doctors (10% in 6 months)
Total competitor prescribers × 10%
240 doctors
Revenue per doctor / month
Monthly revenue per MR ÷ 80 doctors
₹3.8K/mo
New revenue / year
Convertible doctors × Revenue per doctor × 12 months
₹1.08Cr/yr
The full picture
Minimum losing today / year
₹1.35Cr/yr
Opportunity with RouteX / year
₹1.75Cr/yr
Combined annual impact
₹3.10Cr/yr
The loss is what you're already experiencing. The opportunity is what becomes accessible once your field force has real-time visit verification, missed visit alerts, and RCPA intelligence. Combined, they represent the full annual value of RouteX for your team.
RouteX cost / month (Dominate)
₹1.10L/mo
Annual RouteX cost
₹13.19L/yr
Cost as % of team monthly revenue
0.37% of revenue
Combined impact vs annual cost
23.5× RouteX annual cost
Payback period
16 days
RouteX pays for itself in 16 days.
Based on combined annual impact (loss recovered + opportunity unlocked) vs annual RouteX cost at Dominate pricing.
Based on combined annual impact (loss recovered + opportunity unlocked) vs annual RouteX cost at Dominate pricing.
Annual RouteX cost (Dominate)
₹13.19L/yr
vs ₹3.10Cr combined annual impact
Book a Demo — See RouteX in Action See Pricing →
All assumptions are conservative and based on observed Indian pharma field force behaviour patterns.
Your actual results will depend on territory type, therapy area, and field force quality.
Your actual results will depend on territory type, therapy area, and field force quality.